Figure 1 - Change in Monthly Migraine Days (MMD) (Weeks 21-24)

AEON Biopharma

p=0.2844 (150 U vs. Placebo); and p=0.1711 (195 U vs. Placebo)

Format

JPEG

Quelle:

AEON Biopharma

Downloads